“…Pioneer studies have shown that this antibiotic induces antinociceptive effects in chronic constriction nerve or streptozotocin injury-induced neuropathic pain (Amin, Hajhashemi, Abnous, & Hosseinzadeh, 2014;Amin, Hajhashemi, Hosseinzadeh, & Abnous, 2012;Gunduz, Oltulu, Buldum, Guven, & Ulugol, 2011;Hajhashemi, Hosseinzadeh, & Amin, 2013;Hu et al, 2010;Pottabathini, Kumar, Bhatnagar, Garg, & Ekavali, 2016;Shi, Jiang, & Li, 2016;Ochoa-Aguilar et al, 2017;Eljaja, Bjerrum, Honoré, & Abrahamsen, 2011). However, this compound has been less studied in inflammatory pain (Ochoa-Aguilar et al, 2018;Stepanovic-Petrovic, Micov, Tomic, Kovacevic, & Boškovic, 2014). In this sense, CFX produced antinociception after intraperitoneal or local administration in both somatic and visceral inflammatory pain (Stepanovic-Petrovic et al, 2014).…”